Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 13 years, the highest Dividend Payout Ratio of Beijing Tiantan Biological Products was 0.49. The lowest was 0.07. And the median was 0.19.
During the past 12 months, Beijing Tiantan Biological Products's average Dividends Per Share Growth Rate was 66.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 44.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 35.30% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Beijing Tiantan Biological Products was 78.30% per year. The lowest was -37.90% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600161 vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, Beijing Tiantan Biological Products's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Tiantan Biological Products Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Beijing Tiantan Biological Products's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Beijing Tiantan Biological Products's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Beijing Tiantan Biological Products Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.150000
2025-09-25
2025-09-24
2025-09-25
Cash Dividend
semi-annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tiantan Biological Products (SHSE:600161) has a Dividend Yield % of 1.19% as of Jul. 16, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Beijing Tiantan Biological Products and its competitors. This is 153% above median its historical median of 0.47. Over the past decade, Beijing Tiantan Biological Products' Dividend Yield % has ranged from 0.09 to 2.19. According to the industry distribution chart, Beijing Tiantan Biological Products ranks #83 out of 152 companies in the Biotechnology industry, placing it in the top 54.6%.
Is Beijing Tiantan Biological Products' Dividend Yield % too high?
Beijing Tiantan Biological Products' current Dividend Yield % of 1.19% is 153% above median its 10-year median of 0.47. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 2.19. The Biotechnology industry median Dividend Yield % is 1.32. Beijing Tiantan Biological Products' value of 1.19% is 9.8% below this industry median. Based on the distribution chart, Beijing Tiantan Biological Products ranks #83 out of 152 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Beijing Tiantan Biological Products has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tiantan Biological Products' Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Tiantan Biological Products ranks #83 out of 152 companies for Dividend Yield %. This places Beijing Tiantan Biological Products in the lower half of its industry. The industry median Dividend Yield % is 1.32. Beijing Tiantan Biological Products' value of 1.19% is 9.8% below this benchmark. Historically, Beijing Tiantan Biological Products' own Dividend Yield % has ranged from 0.09 to 2.19 over the past decade. While the company's 10-year median is 0.47 vs. the industry median of 1.32, Beijing Tiantan Biological Products has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.32, based on 152 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Tiantan Biological Products's current Dividend Yield % of 1.19% is 9.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Beijing Tiantan Biological Products and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Tiantan Biological Products's current Dividend Yield % is 1.19%, which is 153% above median its own 10-year median of 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tiantan Biological Products stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products (SHSE:600161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥23.94, compared to a current price of ¥12.95 — trading 45.9% below its estimated fair value. The current Dividend Yield % is 1.19%, which is 153% above median its 10-year median of 0.47 and 9.8% below the Biotechnology industry median of 1.32. Beijing Tiantan Biological Products' overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Beijing Tiantan Biological Products (SHSE:600161), the current Dividend Yield % is 1.19% as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Tiantan Biological Products (SHSE:600161) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products stock appears to be undervalued.
The current stock price of ¥12.95 is trading 45.9% below its estimated GF Value™ of ¥23.94.
GuruFocus considers Beijing Tiantan Biological Products to be Significantly Undervalued.
Key valuation signals for SHSE:600161:
Dividend Yield %: 1.19% (153% above median its 10-year median of 0.47)
GF Value™: ¥23.94 vs. price of ¥12.95 (45.9% below fair value)
Industry Position: 9.8% below the Biotechnology median (#83 of 152)
No single metric tells the full story. See the SHSE:600161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Tiantan Biological Products Business Description
Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business. The company's main products include human albumin, human immunoglobulin (pH4) for intravenous injection, human hepatitis B immunoglobulin, human immunoglobulin, human rabies immunoglobulin, human histamine immunoglobulin, and others.
75GF Score
Get the complete analysis for SHSE:600161
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600161 has been successfully added to your 
